Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 24:37:83.
doi: 10.47176/mjiri.37.83. eCollection 2023.

Prevalence of Gestational Diabetes in Iran: A Systematic Review and Meta-analysis

Affiliations
Review

Prevalence of Gestational Diabetes in Iran: A Systematic Review and Meta-analysis

Sara Sadeghi et al. Med J Islam Repub Iran. .

Abstract

Background: Pregnant women who have gestational diabetes mellitus (GDM) are more prone to adverse pregnancy outcomes. We estimated the prevalence of GDM in Iran.

Methods: Web of Science, Scopus, PubMed, Google Scholar, and Persian databases (SID, Magiran, Irandoc, and) were searched using the MeSH and non-MeSH terms in abstract, title, or keywords of articles until June 2021, with no limitation in time. Random effects models were applied to summarize the GDM prevalence in Iran. The obtained data were quantitatively analyzed to determine an effect size for each paper. The pooled effect size was introduced as prevalence and 95% confidence interval. Sensitivity analyses and subgroup analyses were done to determine heterogeneity. Publication bias was assessed by the classic fail-safe N and Egger test.

Results: A total of 53 papers were considered for meta-analysis, involving 56,521 Iranians. The total GDM prevalence in Iran was 7.6% (95% CI, 6.1%-9.4%).

Conclusion: This meta-analysis was the newest to estimate the GDM prevalence among Iranian women. Our results suggest a high prevalence of GDM in Iran, showing that Iran might have many GDM patients.

Keywords: Gestational Diabetes Mellitus; Iran; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors decle that they have no competing interests.

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5
Figure 6
Figure 6

Similar articles

Cited by

References

    1. Choudhury AA, Devi Rajeswari. Gestational diabetes mellitus - A metabolic and reproductive disorder. Biomed Pharmacother. 2021;143:112183. - PubMed
    1. Macaulay S, Dunger DB, Norris SA. Gestational diabetes mellitus in Africa: a systematic review. PLoS One. 2014;9(6):e97871. - PMC - PubMed
    1. Knox CA, Delaney JA, Winterstein AG. Anti-diabetic drug utilization of pregnant diabetic women in us managed care. BMC Pregnancy Childbirth. 2014;14:28. - PMC - PubMed
    1. Kim HY, Kim J, Noh E, Ahn KH, Cho GJ, Hong SC. et al. Prepregnancy hemoglobin levels and gestational diabetes mellitus in pregnancy. Diabetes Res Clin Pract. 2021;171:108608. - PubMed
    1. Egan AM, Vellinga A, Harreiter J, Simmons D, Desoye G, Corcoy R. et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017;60(10):1913. - PMC - PubMed

LinkOut - more resources